Chien-Hsing Chang

Overview

Best Publications

• A Novel Method of 18F Radiolabeling for PET

  William J. McBride;Robert M. Sharkey;Habibe Karacay;Christopher A. D'Souza

  476
  Citations

• Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting

  Edmund A. Rossi;David M. Goldenberg;Thomas M. Cardillo;William J. McBride

  379
  Citations

• Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers.

  Thomas M. Cardillo;Serengulam V. Govindan;Robert M. Sharkey;Preeti Trisal

  309
  Citations

• CD74: A New Candidate Target for the Immunotherapy of B-Cell Neoplasms

  Rhona Stein;M. Jules Mattes;Thomas M. Cardillo;Hans J. Hansen

  304
  Citations

• Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group

  Jean-François Chatal;Loïc Campion;Françoise Kraeber-Bodéré;Stephane Bardet

  298
  Citations

• Multifunctional Antibodies by the Dock-and-Lock Method for Improved Cancer Imaging and Therapy by Pretargeting

  David M. Goldenberg;Edmund A. Rossi;Robert M. Sharkey;William J. McBride

  291
  Citations

• Multivalent Immunoglobulin-Based Bioactive Assemblies

  Chien-Hsing Chang;David M. Goldenberg;Edmund A. Rossi

  274
  Citations

• Improved 18F Labeling of Peptides with a Fluoride-Aluminum-Chelate Complex

  William J. McBride;Christopher A. D’Souza;Robert M. Sharkey;Habibe Karacay

  265
  Citations

• Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody.

  David M. Goldenberg;Edmund A. Rossi;Rhona Stein;Thomas M. Cardillo

  239
  Citations

• Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody.

  Robert M Sharkey;Thomas M Cardillo;Edmund A Rossi;Chien-Hsing Chang

  205
  Citations

• Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.

  Chien-Hsing Chang;Robert M. Sharkey;Edmund A. Rossi;Habibe Karacay

  204
  Citations

• Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab

  Edmund A. Rossi;David M. Goldenberg;Rosana Michel;Diane L. Rossi

  191
  Citations

• Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2–SN-38 Antibody Conjugate (Sacituzumab Govitecan)

  Robert M. Sharkey;William J. McBride;Thomas M. Cardillo;Serengulam V. Govindan

  184
  Citations

• Combination therapy for inducing immune response to disease

  Chien-Hsing Chang;David M. Goldenberg;Edmund A. Rossi;Diane Rossi

  177
  Citations

• The dock and lock method: a novel platform technology for building multivalent, multifunctional structures of defined composition with retained bioactivity.

  Chien-Hsing Chang;Edmund A. Rossi;David M. Goldenberg

  174
  Citations

• Targeting, Toxicity, and Efficacy of 2-Step, Pretargeted Radioimmunotherapy Using a Chimeric Bispecific Antibody and 131I-Labeled Bivalent Hapten in a Phase I Optimization Clinical Trial

  Françoise Kraeber-Bodéré;Caroline Rousseau;Caroline Bodet-Milin;Ludovic Ferrer

  165
  Citations

• Improving the Delivery of Radionuclides for Imaging and Therapy of Cancer Using Pretargeting Methods

  Robert M. Sharkey;Habibe Karacay;Thomas M. Cardillo;Chien-Hsing Chang

  164
  Citations

• Bispecific antibodies for inducing apoptosis of tumor and diseased cells

  Chien-Hsing Chang;David M. Goldenberg;Hans J. Hansen;Eva Horak

  163
  Citations

• Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody.

  Robert M. Sharkey;Habibe Karacay;Samuel Litwin;Edmund A. Rossi

  161
  Citations

• Bispecific Antibody Pretargeting PET (ImmunoPET) with an 124I-Labeled Hapten-Peptide

  William J McBride;Pat Zanzonico;Robert M Sharkey;Carl Norén

  153
  Citations